CVE-2022-37461

Name: CVE-2022-37461
Creator: NVD / NIST
Published: 2022-09-30T14:15:09.537+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 6.1/10EPSS 0.92%

Last modified Jun 17, 2026

CVE-2022-37461 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.. EPSS estimates a 0.92% chance of exploitation in the next 30 days.

Description

Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.

Metrics

CVSS 3.1

6.1/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

EPSS Probability

0.92%

55.8th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Vendor	Product	Versions
Canon	Medical Vitrea View	>= 7.0, < 7.7.6

References

https://www.trustwave.com/en-us/resources/security-resources/security-advisories/?fid=30693Exploit, Third Party Advisory
https://www.vitalimages.com/customer-success-support-program/vital-images-software-security-updates/Vendor Advisory
https://www.vitalimages.com/vitrea-vision/vitrea-view/Product, Vendor Advisory
https://www.trustwave.com/en-us/resources/security-resources/security-advisories/?fid=30693Exploit, Third Party Advisory
https://www.vitalimages.com/customer-success-support-program/vital-images-software-security-updates/Vendor Advisory
https://www.vitalimages.com/vitrea-vision/vitrea-view/Product, Vendor Advisory

Timeline

Published: Sep 30, 2022
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2022-37461?

How severe is CVE-2022-37461?

CVE-2022-37461 has a CVSS score of 6.1/10 (MEDIUM severity). The EPSS model estimates a 0.92% probability of exploitation in the next 30 days.

How do I fix CVE-2022-37461?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-37461?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST